Results 231 to 240 of about 36,520 (265)
Some of the next articles are maybe not open access.
Fundus autofluorescence lifetimes are increased in non‐proliferative diabetic retinopathy
Acta Ophthalmologica, 2016AbstractPurposeTo discriminate non‐proliferative diabetic retinopathy (NPDR) patients from healthy controls by fluorescence lifetime imaging ophthalmoscopy (FLIO).MethodsA prototype FLIO (Heidelberg‐Engineering, Heidelberg, Germany) was used to examine the retina of 33 patients and 28 controls.
Johanna, Schmidt +7 more
openaire +2 more sources
Hierarchical severity grade classification of non-proliferative diabetic retinopathy
Journal of Ambient Intelligence and Humanized Computing, 2020Curability of diabetic retinopathy (DR) abnormalities highly rely on regular monitoring, early-stage diagnosis and timely treatment. Detection and analysis of variation in eye images can help the patient to take the early action before progression of the disease.
Charu Bhardwaj +2 more
openaire +1 more source
Non-proliferative diabetic retinopathy
Disease-a-Month, 2021Dagmara, Danek +2 more
openaire +2 more sources
European Journal of Ophthalmology, 2020
Purpose: To investigate aqueous humor (AH) and serum levels of brain-derived neurotrophic factor (BDNF) in non-proliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME). Methods: The prospective study consists of 20 patients with DME NPDR, 20 patients with no-DME NPDR, and 20 healthy control subjects.
Yong Hyun Jun, Seong Taeck Kim
openaire +2 more sources
Purpose: To investigate aqueous humor (AH) and serum levels of brain-derived neurotrophic factor (BDNF) in non-proliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME). Methods: The prospective study consists of 20 patients with DME NPDR, 20 patients with no-DME NPDR, and 20 healthy control subjects.
Yong Hyun Jun, Seong Taeck Kim
openaire +2 more sources
Non proliferative diabetic retinopathy and macular edema
Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1999As previously noted, although visual loss usually does not fall below 20/200 in the presence of ME, it may nevertheless be a significant disability. Additional interventions may include referral to low vision clinics, home health agencies, visual loss support groups, and local or regional blindness agencies to aid the patient's occupational ...
openaire +2 more sources
Non-proliferative diabetic retinopathy symptoms detection and classification using neural network
Journal of Medical Engineering & Technology, 2017Diabetic retinopathy (DR) causes blindness in the working age for people with diabetes in most countries. The increasing number of people with diabetes worldwide suggests that DR will continue to be major contributors to vision loss. Early detection of retinopathy progress in individuals with diabetes is critical for preventing visual loss.
Mohammad A, Al-Jarrah, Hadeel, Shatnawi
openaire +2 more sources
Detection and Classification of Non-Proliferative Diabetic Retinopathy Lesions
2019The World Health Organization (WHO) predicted that in the year 2012 about 347 million people worldwide would be suffering from diabetes, and more than 80% deaths occur due to diabetes in different countries. WHO projects that diabetes will be the seventh major cause of death in 2030. Diabetic retinopathy begins with a leakage of blood or fluid from the
Ramesh R. Manza +3 more
openaire +1 more source
Detection of Non-proliferative Diabetic Retinopathy using GUI
2022 2nd International Conference on Innovative Practices in Technology and Management (ICIPTM), 2022Yogesh Kumar, Nikhil Poonia, Prince Jain
openaire +1 more source